Security file · CUSIP 09062X103
BIIB
BIOGEN INC · US listing · held by 2 tracked managers in Q3 2026.
Tracked holders · Q3 2026
2
-1 vs Q2 2026
Aggregate reported value
$60.85M
sum of holders' reported positions
New holders this quarter
0
0 added · 2 trimmed
Holder return since filing
+0.5%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Samantha McLemore - Patient Capital Managementfiled 12 Nov ET | 1.77% | 246K | -13.1% | $250 | +1.7% | $55.68M | Trimmed |
| 2 | Hillman Capital Managementfiled 16 Nov ET | 3.87% | 23K | -4.5% | $255 | +0.0% | $5.17M | Trimmed |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 2 | -1 | $60.85M | 269K |
| Q2 2026 | 3 | +1 | $127M | 586K |
| Q1 2026 | 2 | +0 | $56.89M | 310K |
| Q4 2025 | 2 | +0 | $97.08M | 552K |
| Q3 2025 | 2 | -1 | $135M | 964K |
| Q2 2025 | 3 | +0 | $107M | 856K |
| Q1 2025 | 3 | +1 | $128M | 933K |
| Q4 2024 | 2 | +1 | $49.66M | 325K |
| Q3 2024 | 1 | +0 | $6.83M | 35K |
| Q2 2024 | 1 | +0 | $8.33M | 36K |
| Q1 2024 | 1 | +0 | $7.72M | 36K |
| Q4 2023 | 1 | -1 | $414K | 1,600 |
| Q3 2023 | 2 | +0 | $9.06M | 35K |
| Q2 2023 | 2 | — | $8.66M | 30K |